▶ 調査レポート

インスリンのグローバル市場 2021年:企業別、地域別、種類・用途別

• 英文タイトル:Global Insulin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。インスリンのグローバル市場 2021年:企業別、地域別、種類・用途別 / Global Insulin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-203B16438資料のイメージです。• レポートコード:GIR-203B16438
• 出版社/出版日:GlobalInfoResearch / 2021年12月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
インスリン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のインスリンの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx%の変化があります。世界のインスリンの市場規模は次の5年間でxxx%のCAGRで成長すると予想されます。

インスリン市場は種類と用途によって区分されます。2016年~2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・動物インスリン、レギュラーヒトインスリン、インスリンアナログ

用途別セグメントは次のように区分されます。
・短時間作用型、中型作用型、長時間作用型、プレミックスインスリン

世界のインスリン市場の主要な市場プレーヤーは以下のとおりです。
・Novo Nordisk、Eli Lilly、Sanofi-Aventis、Tonghua Dongbao、Ganlee、United Laboratory、Jiangsu Wanbang

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計14章あります。
・第1章では、インスリン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なインスリンメーカーの企業概要、2019年~2021年までのインスリンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なインスリンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2016年~2026年までの地域別インスリンの販売量、売上、成長性を示しています。
・第5、6章では、2016年~2026年までのインスリンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2016年~2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年~2026年までの主要地域でのインスリン市場予測を収録しています。
・第12、13、14章では、インスリンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Novo Nordisk、Eli Lilly、Sanofi-Aventis、Tonghua Dongbao、Ganlee、United Laboratory、Jiangsu Wanbang
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:動物インスリン、レギュラーヒトインスリン、インスリンアナログ
・用途別分析2016年-2026年:短時間作用型、中型作用型、長時間作用型、プレミックスインスリン
・インスリンの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・インスリンのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・インスリンのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・インスリンの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・インスリンの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Insulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Insulin size is estimated to be XX million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Insulin market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Insulin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Animal Insulin
Regular Human Insulin
Insulin Analogue

Market segment by Application can be divided into
Short Acting
Intermediate Acting
Long Acting
Pre-Mix Insulin

The key market players for global Insulin market are listed below:
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Insulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin, with price, sales, revenue and global market share of Insulin from 2019 to 2021.
Chapter 3, the Insulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Insulin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Insulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Insulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Insulin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Animal Insulin
1.2.3 Regular Human Insulin
1.2.4 Insulin Analogue
1.3 Market Analysis by Application
1.3.1 Overview: Global Insulin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Global Insulin Market Size & Forecast
1.4.1 Global Insulin Sales in Value (2016-2026))
1.4.2 Global Insulin Sales in Volume (2016-2026)
1.4.3 Global Insulin Price by Type (2016-2026) & (US$/Pcs)
1.5 Global Insulin Production Capacity Analysis
1.5.1 Global Insulin Total Production Capacity (2016-2026)
1.5.2 Global Insulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Insulin Market Drivers
1.6.2 Insulin Market Restraints
1.6.3 Insulin Trends Analysis
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Insulin Product and Services
2.1.4 Novo Nordisk Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Eli Lilly
2.2.1 Eli Lilly Details
2.2.2 Eli Lilly Major Business
2.2.3 Eli Lilly Insulin Product and Services
2.2.4 Eli Lilly Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business
2.3.3 Sanofi-Aventis Insulin Product and Services
2.3.4 Sanofi-Aventis Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Tonghua Dongbao
2.4.1 Tonghua Dongbao Details
2.4.2 Tonghua Dongbao Major Business
2.4.3 Tonghua Dongbao Insulin Product and Services
2.4.4 Tonghua Dongbao Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Ganlee
2.5.1 Ganlee Details
2.5.2 Ganlee Major Business
2.5.3 Ganlee Insulin Product and Services
2.5.4 Ganlee Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 United Laboratory
2.6.1 United Laboratory Details
2.6.2 United Laboratory Major Business
2.6.3 United Laboratory Insulin Product and Services
2.6.4 United Laboratory Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Jiangsu Wanbang
2.7.1 Jiangsu Wanbang Details
2.7.2 Jiangsu Wanbang Major Business
2.7.3 Jiangsu Wanbang Insulin Product and Services
2.7.4 Jiangsu Wanbang Insulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Insulin Sales by Manufacturer
3.1 Global Insulin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Insulin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Insulin
3.4 Market Concentration Rate
3.4.1 Top 3 Insulin Manufacturer Market Share
3.4.2 Top 6 Insulin Manufacturer Market Share
3.5 Global Insulin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Insulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Insulin Market Size by Region
4.1.1 Global Insulin Sales in Volume by Region (2016-2026)
4.1.2 Global Insulin Revenue by Region (2016-2026)
4.2 North America Insulin Revenue (2016-2026)
4.3 Europe Insulin Revenue (2016-2026)
4.4 Asia-Pacific Insulin Revenue (2016-2026)
4.5 South America Insulin Revenue (2016-2026)
4.6 Middle East and Africa Insulin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Insulin Sales in Volume by Type (2016-2026)
5.2 Global Insulin Revenue by Type (2016-2026)
5.3 Global Insulin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Insulin Sales in Volume by Application (2016-2026)
6.2 Global Insulin Revenue by Application (2016-2026)
6.3 Global Insulin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Insulin Sales by Type (2016-2026)
7.2 North America Insulin Sales by Application (2016-2026)
7.3 North America Insulin Market Size by Country
7.3.1 North America Insulin Sales in Volume by Country (2016-2026)
7.3.2 North America Insulin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Insulin Sales by Type (2016-2026)
8.2 Europe Insulin Sales by Application (2016-2026)
8.3 Europe Insulin Market Size by Country
8.3.1 Europe Insulin Sales in Volume by Country (2016-2026)
8.3.2 Europe Insulin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Insulin Sales by Type (2016-2026)
9.2 Asia-Pacific Insulin Sales by Application (2016-2026)
9.3 Asia-Pacific Insulin Market Size by Region
9.3.1 Asia-Pacific Insulin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Insulin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Insulin Sales by Type (2016-2026)
10.2 South America Insulin Sales by Application (2016-2026)
10.3 South America Insulin Market Size by Country
10.3.1 South America Insulin Sales in Volume by Country (2016-2026)
10.3.2 South America Insulin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Insulin Sales by Type (2016-2026)
11.2 Middle East & Africa Insulin Sales by Application (2016-2026)
11.3 Middle East & Africa Insulin Market Size by Country
11.3.1 Middle East & Africa Insulin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Insulin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Insulin Typical Distributors
12.3 Insulin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Insulin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Insulin Revenue by Application, (USD Million), 2021-2026
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Insulin Product and Services
Table 6. Novo Nordisk Insulin Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly Major Business
Table 9. Eli Lilly Insulin Product and Services
Table 10. Eli Lilly Insulin Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi-Aventis Major Business
Table 13. Sanofi-Aventis Insulin Product and Services
Table 14. Sanofi-Aventis Insulin Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 16. Tonghua Dongbao Major Business
Table 17. Tonghua Dongbao Insulin Product and Services
Table 18. Tonghua Dongbao Insulin Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Ganlee Basic Information, Manufacturing Base and Competitors
Table 20. Ganlee Major Business
Table 21. Ganlee Insulin Product and Services
Table 22. Ganlee Insulin Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. United Laboratory Basic Information, Manufacturing Base and Competitors
Table 24. United Laboratory Major Business
Table 25. United Laboratory Insulin Product and Services
Table 26. United Laboratory Insulin Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Jiangsu Wanbang Basic Information, Manufacturing Base and Competitors
Table 28. Jiangsu Wanbang Major Business
Table 29. Jiangsu Wanbang Insulin Product and Services
Table 30. Jiangsu Wanbang Insulin Sales (M Pcs), Price (US$/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Insulin Sales by Manufacturer (2019-2021e) & (M Pcs)
Table 32. Global Insulin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Insulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Insulin Production Capacity by Company, (M Pcs): 2020 VS 2021
Table 35. Head Office and Insulin Production Site of Key Manufacturer
Table 36. Insulin New Entrant and Capacity Expansion Plans
Table 37. Insulin Mergers & Acquisitions in the Past Five Years
Table 38. Global Insulin Sales by Region (2016-2021e) & (M Pcs)
Table 39. Global Insulin Sales by Region (2021-2026) & (M Pcs)
Table 40. Global Insulin Revenue by Region (2016-2021e) & (USD Million)
Table 41. Global Insulin Revenue by Region (2021-2026) & (USD Million)
Table 42. Global Insulin Sales by Type (2016-2021e) & (M Pcs)
Table 43. Global Insulin Sales by Type (2021-2026) & (M Pcs)
Table 44. Global Insulin Revenue by Type (2016-2021e) & (USD Million)
Table 45. Global Insulin Revenue by Type (2021-2026) & (USD Million)
Table 46. Global Insulin Price by Type (2016-2021e) & (US$/Pcs)
Table 47. Global Insulin Price by Type (2021-2026) & (US$/Pcs)
Table 48. Global Insulin Sales by Application (2016-2021e) & (M Pcs)
Table 49. Global Insulin Sales by Application (2021-2026) & (M Pcs)
Table 50. Global Insulin Revenue by Application (2016-2021e) & (USD Million)
Table 51. Global Insulin Revenue by Application (2021-2026) & (USD Million)
Table 52. Global Insulin Price by Application (2016-2021e) & (US$/Pcs)
Table 53. Global Insulin Price by Application (2021-2026) & (US$/Pcs)
Table 54. North America Insulin Sales by Country (2016-2021e) & (M Pcs)
Table 55. North America Insulin Sales by Country (2021-2026) & (M Pcs)
Table 56. North America Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 57. North America Insulin Revenue by Country (2021-2026) & (USD Million)
Table 58. North America Insulin Sales by Type (2016-2021e) & (M Pcs)
Table 59. North America Insulin Sales by Type (2021-2026) & (M Pcs)
Table 60. North America Insulin Sales by Application (2016-2021e) & (M Pcs)
Table 61. North America Insulin Sales by Application (2021-2026) & (M Pcs)
Table 62. Europe Insulin Sales by Country (2016-2021e) & (M Pcs)
Table 63. Europe Insulin Sales by Country (2021-2026) & (M Pcs)
Table 64. Europe Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 65. Europe Insulin Revenue by Country (2021-2026) & (USD Million)
Table 66. Europe Insulin Sales by Type (2016-2021e) & (M Pcs)
Table 67. Europe Insulin Sales by Type (2021-2026) & (M Pcs)
Table 68. Europe Insulin Sales by Application (2016-2021e) & (M Pcs)
Table 69. Europe Insulin Sales by Application (2021-2026) & (M Pcs)
Table 70. Asia-Pacific Insulin Sales by Region (2016-2021e) & (M Pcs)
Table 71. Asia-Pacific Insulin Sales by Region (2021-2026) & (M Pcs)
Table 72. Asia-Pacific Insulin Revenue by Region (2016-2021e) & (USD Million)
Table 73. Asia-Pacific Insulin Revenue by Region (2021-2026) & (USD Million)
Table 74. Asia-Pacific Insulin Sales by Type (2016-2021e) & (M Pcs)
Table 75. Asia-Pacific Insulin Sales by Type (2021-2026) & (M Pcs)
Table 76. Asia-Pacific Insulin Sales by Application (2016-2021e) & (M Pcs)
Table 77. Asia-Pacific Insulin Sales by Application (2021-2026) & (M Pcs)
Table 78. South America Insulin Sales by Country (2016-2021e) & (M Pcs)
Table 79. South America Insulin Sales by Country (2021-2026) & (M Pcs)
Table 80. South America Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 81. South America Insulin Revenue by Country (2021-2026) & (USD Million)
Table 82. South America Insulin Sales by Type (2016-2021e) & (M Pcs)
Table 83. South America Insulin Sales by Type (2021-2026) & (M Pcs)
Table 84. South America Insulin Sales by Application (2016-2021e) & (M Pcs)
Table 85. South America Insulin Sales by Application (2021-2026) & (M Pcs)
Table 86. Middle East & Africa Insulin Sales by Country (2016-2021e) & (M Pcs)
Table 87. Middle East & Africa Insulin Sales by Country (2021-2026) & (M Pcs)
Table 88. Middle East & Africa Insulin Revenue by Country (2016-2021e) & (USD Million)
Table 89. Middle East & Africa Insulin Revenue by Country (2021-2026) & (USD Million)
Table 90. Middle East & Africa Insulin Sales by Type (2016-2021e) & (M Pcs)
Table 91. Middle East & Africa Insulin Sales by Type (2021-2026) & (M Pcs)
Table 92. Middle East & Africa Insulin Sales by Application (2016-2021e) & (M Pcs)
Table 93. Middle East & Africa Insulin Sales by Application (2021-2026) & (M Pcs)
Table 94. Direct Channel Pros & Cons
Table 95. Indirect Channel Pros & Cons
Table 96. Insulin Typical Distributors
Table 97. Insulin Typical Customers
List of Figures
Figure 1. Insulin Picture
Figure 2. Global Insulin Sales Market Share by Type in 2020
Figure 3. Animal Insulin
Figure 4. Regular Human Insulin
Figure 5. Insulin Analogue
Figure 6. Global Insulin Sales Market Share by Application in 2020
Figure 7. Short Acting
Figure 8. Intermediate Acting
Figure 9. Long Acting
Figure 10. Pre-Mix Insulin
Figure 11. Global Insulin Market Size, (USD Million) & (M Pcs): 2020 VS 2021 VS 2026
Figure 12. Global Insulin Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Insulin Sales (2016-2026) & (M Pcs)
Figure 14. Global Insulin Price by Type (2016-2026) & (US$/Pcs)
Figure 15. Global Insulin Production Capacity (2016-2026) & (M Pcs)
Figure 16. Global Insulin Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Insulin Market Drivers
Figure 18. Insulin Market Restraints
Figure 19. Insulin Market Trends
Figure 20. Global Insulin Sales Market Share by Manufacturer in 2020
Figure 21. Global Insulin Revenue Market Share by Manufacturer in 2020
Figure 22. Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Insulin Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Insulin Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Insulin Sales Market Share by Region (2016-2026)
Figure 26. Global Insulin Revenue Market Share by Region (2016-2026)
Figure 27. North America Insulin Revenue (2016-2026) & (USD Million)
Figure 28. Europe Insulin Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Insulin Revenue (2016-2026) & (USD Million)
Figure 30. South America Insulin Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Insulin Revenue (2016-2026) & (USD Million)
Figure 32. Global Insulin Sales Market Share by Type (2016-2026)
Figure 33. Global Insulin Revenue Market Share by Type (2016-2026)
Figure 34. Global Insulin Price by Type (2016-2026) & (US$/Pcs)
Figure 35. Global Insulin Sales Market Share by Application (2016-2026)
Figure 36. Global Insulin Revenue Market Share by Application (2016-2026)
Figure 37. Global Insulin Price by Application (2016-2026) & (US$/Pcs)
Figure 38. North America Insulin Sales Market Share by Type (2016-2026)
Figure 39. North America Insulin Sales Market Share by Application (2016-2026)
Figure 40. North America Insulin Sales Market Share by Country (2016-2026)
Figure 41. North America Insulin Revenue Market Share by Country (2016-2026)
Figure 42. United States Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Insulin Sales Market Share by Type (2016-2026)
Figure 46. Europe Insulin Sales Market Share by Application (2016-2026)
Figure 47. Europe Insulin Sales Market Share by Country (2016-2026)
Figure 48. Europe Insulin Revenue Market Share by Country (2016-2026)
Figure 49. Germany Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Insulin Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Insulin Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Insulin Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Insulin Revenue Market Share by Region (2016-2026)
Figure 58. China Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Insulin Sales Market Share by Type (2016-2026)
Figure 65. South America Insulin Sales Market Share by Application (2016-2026)
Figure 66. South America Insulin Sales Market Share by Country (2016-2026)
Figure 67. South America Insulin Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Insulin Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Insulin Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Insulin Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Insulin Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Insulin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source